FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

We believe SVT-001 provides true hope to prevent the almost inevitable vision loss caused by this devastating condition ...

Discover five key lifestyle changes that can help reduce your risk of age-related macular degeneration, a leading cause of ...

New research shows smoking changes how key eye cells control genes, helping explain why smokers face a much higher risk of ...

In 2019, 57 million people worldwide were living with dementia, a figure expected to soar to 153 million by 2050. A recent Lancet Commission report suggests that nearly half of dementia cases could be ...

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in the process. A review published in JAMA Ophthalmology uncovered at least ...

Gaze patterns vary substantially among people with varying levels of vision, pointing to the need for individualized ...

New research links a rare and blinding eye condition to semaglutide. Semaglutide is the active ingredient in Ozempic and Wegovy. Doctors recommend that people don't panic over the findings. There’s ...

The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect ...

Residents living with vision loss had the opportunity to explore new assistive technology and support services during a visit from the Canadian National Institute for the Blind Mobile Hub in Humboldt ...